Semax Dosage Guide & Research Calculator
This semax dosage guide compiles reconstitution math, an embedded concentration calculator, and dose ranges for the heptapeptide semax reported in published preclinical and early clinical research literature. All figures below summarize parameters reported in published preclinical or in-vitro research. They are provided for reference only and are not instructions for human or veterinary administration.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.
Semax reconstitution math & semax dosage calculator
Reconstituting a lyophilized peptide gives a solution with a known concentration. The formula is simple:
Worked example: Adding 2 mL of bacteriostatic water to a 10 mg vial of semax yields 5,000 mcg/mL. 0.06 mL (6 units on a U-100 insulin syringe) of that solution contains ~300 mcg of peptide.
Enter your values
The total mass of lyophilized powder listed on the vial label.
The volume of bacteriostatic water added to the vial.
The amount, in micrograms, to model in your concentration math (1 mg = 1,000 mcg).
Display volume in U-100 syringe units or plain mL.
Based on your inputs
This tool performs unit conversion and concentration math for research planning. It is not medical advice, not a dose recommendation, and not intended for human or veterinary use.
Semax doses reported in published preclinical research
The figures below summarize Semax doses that appear in published animal-model or in-vitro studies. They describe what researchers have used in laboratory settings — they are not human administration protocols and are not dose recommendations.
| Research context | Dose reported | Notes |
|---|---|---|
| Rodent model, intranasal | 50–250 µg/kg | Range reported in published neuroprotection-research studies. |
| Rodent model, intraperitoneal | 150 µg/kg | Commonly cited dose in animal-model literature. |
| Published early clinical research, intranasal | 0.1%–1% solution | Concentrations referenced in published Russian clinical-research literature. |
All values are research-context references compiled from published preclinical and in-vitro literature. Semax is supplied for laboratory and research use only.
Continue your Semax research
Semax research dosage — frequently asked questions
How is semax reconstituted for research?+
Lyophilized semax is dissolved in bacteriostatic water in the laboratory. Concentration is calculated as (vial mg × 1000) ÷ diluent mL, giving mcg per mL.
What concentration does 10 mg semax in 2 mL give?+
10 mg in 2 mL of bacteriostatic water yields a 5,000 mcg/mL solution. 0.06 mL (6 units on a U-100 insulin syringe) contains roughly 300 mcg.
What semax doses are reported in published research?+
Published rodent studies most commonly reference intranasal doses of 50–250 µg/kg and intraperitoneal doses around 150 µg/kg. Early clinical-research literature references 0.1%–1% intranasal solutions.
Is this semax dosage guide for human use?+
No. Semax is supplied for laboratory and research use only. The figures above describe parameters reported in published research and are not human administration instructions.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.